Adequate Antibody Response to COVID-19 Vaccine in Patients with Monoclonal Gammopathies and Light Chain Amyloidosis.

Alan H B WuChia-Ching WangChui Mei OngKara L Lynch

Published in: Laboratory medicine (2022)

After receiving a COVID-19 vaccine, most patients with MG produce anti-SARS-CoV-2 antibodies comparable to levels in uninfected vaccinated healthy control patients.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
chronic kidney disease
ejection fraction
newly diagnosed
multiple myeloma
peritoneal dialysis
hiv infected
patient reported outcomes